GR3023065T3 - Pressurised aerosol compositions - Google Patents

Pressurised aerosol compositions

Info

Publication number
GR3023065T3
GR3023065T3 GR970400733T GR970400733T GR3023065T3 GR 3023065 T3 GR3023065 T3 GR 3023065T3 GR 970400733 T GR970400733 T GR 970400733T GR 970400733 T GR970400733 T GR 970400733T GR 3023065 T3 GR3023065 T3 GR 3023065T3
Authority
GR
Greece
Prior art keywords
pressurised aerosol
surfactant
propellant
aerosol compositions
medicament
Prior art date
Application number
GR970400733T
Other languages
English (en)
Inventor
Asit Somani
Clive Booles
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014527A external-priority patent/GB9014527D0/en
Priority claimed from GB909014526A external-priority patent/GB9014526D0/en
Priority claimed from GB909023953A external-priority patent/GB9023953D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of GR3023065T3 publication Critical patent/GR3023065T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
GR970400733T 1990-06-29 1997-04-08 Pressurised aerosol compositions GR3023065T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909014527A GB9014527D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909014526A GB9014526D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909023953A GB9023953D0 (en) 1990-11-03 1990-11-03 Pharmaceutical composition
PCT/GB1991/001023 WO1992000061A1 (en) 1990-06-29 1991-06-25 Pressurised aerosol compositions

Publications (1)

Publication Number Publication Date
GR3023065T3 true GR3023065T3 (en) 1997-07-30

Family

ID=27265168

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400733T GR3023065T3 (en) 1990-06-29 1997-04-08 Pressurised aerosol compositions

Country Status (21)

Country Link
US (1) US5846521A (el)
EP (1) EP0536235B1 (el)
JP (1) JP2854974B2 (el)
AT (1) ATE147973T1 (el)
AU (1) AU8055691A (el)
BR (1) BR9106595A (el)
CA (1) CA2085884C (el)
CZ (1) CZ392592A3 (el)
DE (1) DE69124374T2 (el)
DK (1) DK0536235T3 (el)
ES (1) ES2096653T3 (el)
FI (1) FI925852A (el)
GR (1) GR3023065T3 (el)
HU (1) HUT63554A (el)
IE (1) IE912220A1 (el)
MX (1) MX9100008A (el)
NO (1) NO924954L (el)
NZ (1) NZ238746A (el)
PT (1) PT98133A (el)
SK (1) SK392592A3 (el)
WO (1) WO1992000061A1 (el)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
DE69231991T2 (de) 1991-06-10 2002-04-04 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
ES2158911T5 (es) * 1991-06-10 2009-12-09 Schering Corporation Formulaciones en aerosol sin clorofluorocarbonos.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
WO1994021228A1 (en) * 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
ES2122261T3 (es) * 1993-03-17 1998-12-16 Minnesota Mining & Mfg Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
CA2176249C (en) * 1993-12-02 2010-06-01 Akwete L. Adjei Aerosol drug formulations for use with non-cfc propellants
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
DK1014943T3 (da) 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
NZ509328A (en) 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ES2193726T3 (es) 1998-08-04 2003-11-01 Jago Res Ag Formulaciones de aerosol medicinales.
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
US7217409B2 (en) 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
EP1345629A2 (en) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
JP4959919B2 (ja) * 2001-12-21 2012-06-27 スリーエム イノベイティブ プロパティズ カンパニー 官能基を有するポリエチレングリコール賦形剤を用いた医薬用エアロゾル組成物
NZ533831A (en) 2002-02-13 2006-04-28 Glaxo Group Ltd Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
JP4607112B2 (ja) 2003-08-11 2011-01-05 グラクソ グループ リミテッド 医薬定量噴霧式吸入器及び前記吸引器に関連する方法
US20080190418A1 (en) 2003-08-29 2008-08-14 Glaxo Group Limited Pharmaceutical Metered Dose Inhaler and Methods Relating Thereto
KR20090129998A (ko) 2007-02-11 2009-12-17 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
WO1988007855A1 (en) * 1987-04-09 1988-10-20 Fisons Plc Pharmaceutical compositions containing pentamidine
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8828544D0 (en) * 1988-12-07 1989-01-11 Ici Plc Chemical process
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments

Also Published As

Publication number Publication date
HU9204098D0 (en) 1993-03-29
US5846521A (en) 1998-12-08
PT98133A (pt) 1992-04-30
SK392592A3 (en) 1994-07-06
HUT63554A (en) 1993-09-28
CA2085884C (en) 2001-12-04
WO1992000061A1 (en) 1992-01-09
FI925852A0 (fi) 1992-12-23
IE912220A1 (en) 1992-01-01
DE69124374T2 (de) 1997-06-19
AU8055691A (en) 1992-01-23
CZ392592A3 (en) 1993-05-12
BR9106595A (pt) 1993-04-20
JPH05507712A (ja) 1993-11-04
NO924954D0 (no) 1992-12-21
CA2085884A1 (en) 1991-12-30
ATE147973T1 (de) 1997-02-15
ES2096653T3 (es) 1997-03-16
NZ238746A (en) 1992-10-28
NO924954L (no) 1992-12-21
DK0536235T3 (da) 1997-04-14
DE69124374D1 (de) 1997-03-06
MX9100008A (es) 1992-02-03
JP2854974B2 (ja) 1999-02-10
EP0536235A1 (en) 1993-04-14
FI925852A (fi) 1992-12-23
EP0536235B1 (en) 1997-01-22

Similar Documents

Publication Publication Date Title
GR3023065T3 (en) Pressurised aerosol compositions
IL97065A0 (en) Aerosol propellant compositions
NZ333986A (en) Aerosol formulation comprising a medicament, a fluorocarbon propellant, 6-25% of a polar co-solvent and being substantially free of surfactant
BG102689A (en) Pharmaceutical aerosol composition
FR2688422B1 (el)
FI962478A0 (fi) Uusia vaahtoihin, etenkin rektaalisiin vaahtoihin tarkoitettuja koostumuksia ja näistä valmistettuja vaahtoja
EP0366154A3 (en) Use of a composition as a cosmetic product
CA2062779A1 (en) Sterilizing gas composition comprising monochlorotetrafluorethane and ethylene oxide
EP0047122A3 (en) Intranasal formulation
TW365607B (en) Nonionic foaming agent for foaming cosmetic compositions
CA2176458A1 (en) Foaming Agent for Leave-On Foaming Cosmetic Compositions
JPS51116185A (en) An aerosol composition
ES2087036A1 (es) Pomada de accion rapida contra las varices.
MY107927A (en) Prewash cleaner compositions
RU92016480A (ru) Аэрозольные композиции, содержащие лекарственный препарат
MY108690A (en) Mildewproofing agent for timber
MX9707807A (es) Agente generador de espuma no ionico para composiciones cosmeticas espumosas.
CA2141039A1 (en) Surfactant free aerosol formulations containing beclomethasone dipropionate
MX9704888A (es) Dispositivo para el almacenamiento separado de al menos dos productos, su mezcla y la distribucion de la mezcla obtenida de este modo y el procedimiento de fabricacion.